BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA)

Lobbying client · filed 2025 to 2026

Life Sciences R&D

$10,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (69475), not by name.

Firms hired 1

TRUSYNERGY $10,000 5 filings

Reported by year 2 years

2026 $10,000 2 filings
2025 $0 3 filings

Issues lobbied 1

Health Issues 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 3
SENATE 3

Recent filings 5 total

Q2

TRUSYNERGY

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 14, 2026

View → Q1

TRUSYNERGY

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 14, 2026

View → Q4

TRUSYNERGY

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · posted Jan 9, 2026

View → Q3Y

TRUSYNERGY

3rd Quarter (July 1 - Sep 30) 2025 · posted Nov 11, 2025

View → RR

TRUSYNERGY

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.